REPLIGEN CORP (RGEN) Total assets 2016–2025
REPLIGEN CORP (RGEN) total assets at each fiscal year-end, per SEC filings.
$2.9BFY2025 · since FY2016: $288.9M → $2.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.9B | +4.2% |
| FY2024 | $2.8B | -0.1% |
| FY2023 | $2.8B | +11.8% |
| FY2022 | $2.5B | +7.3% |
| FY2021 | $2.4B | +23.9% |
| FY2020 | $1.9B | +35.9% |
| FY2019 | $1.4B | +80.7% |
| FY2018 | $774.6M | +4.2% |
| FY2017 | $743.5M | +157.4% |
| FY2016 | $288.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGEN financial trends
RGEN RevenueRGEN Net incomeRGEN Net marginRGEN Gross profitRGEN Gross marginRGEN Operating incomeRGEN Operating marginRGEN Operating cash flowRGEN Free cash flowRGEN Capital expendituresRGEN Return on equityRGEN Stock buybacksRGEN Dividends paidRGEN Total liabilitiesRGEN Shareholders’ equityRGEN overview →